by Brad N. Taylor, Ph.D. | Sep 23, 2022
(San Diego, CA – September 23, 2022) — Nucleus Biologics, The Cell Performance Company™, an industry-leading provider of small lot custom cell culture media, celebrated the opening of its newest building on their San Diego campus and the unveiling of additional...
by Brad N. Taylor, Ph.D. | Aug 31, 2022
Cell and gene therapy products are only as good as their cellular building blocks— therefore cell culture media should first and foremost be designed to support consistent and optimal cellular performance. Welcome to Part 2 of our blog series highlighting...
by Brad N. Taylor, Ph.D. | Aug 23, 2022
ISO 13485:2016 certification demonstrates Nucleus Biologics’ commitment to maintaining premium quality standards. (San Diego, CA – August 23, 2022) Nucleus Biologics, The Cell Performance Company™, the industry-leading provider of small lot custom media for the cell...
by Brad N. Taylor, Ph.D. | Aug 9, 2022
The key to every successful therapy is consistency. Cell therapy manufacturers need solutions that allow them to efficiently harness the ability of a living cell to respond to its environment, while simultaneously delivering replicable and consistent quality...
by Brad N. Taylor, Ph.D. | Jul 27, 2022
Cell therapy scale-up is a critical inflection point in the development of any cell-based product. Shrewd consideration of culture media supplements can promote consistency while simplifying regulatory hurdles. Forty percent of the global pharmaceutical product...
